CVS Health to Present at the Barclays Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
CVS Health (CVS) PT Lowered to $68 at Citi
March 6, 2019 7:07 AM ESTCiti analyst Ralph Giacobbe lowered the price target on CVS Health (NYSE: CVS) to $68.00 (from $94.00) while maintaining a Buy rating. Citi continues to field questions post the CVS results/guidance largely around reconciling headwinds for 2019, thoughts on 2020, and debt leverage and CF concerns.... More
